RECOMMENDATION 15 |
We recommend the use of plasma-derived C1 inhibitor as first-line long-term prophylaxis. |
87% agreement, evidence level A |
RECOMMENDATION 15 |
We recommend the use of plasma-derived C1 inhibitor as first-line long-term prophylaxis. |
87% agreement, evidence level A |